Serum ischemia-modified albumin levels at diagnosis and during treatment of late-onset neonatal sepsis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 17, 2014, Pages 1723-1727

  Yerlikaya, F Hümeyra ^a   Kurban, Sevil ^a   Mehmetoglu, Idris ^a   Annagur, Ali ^b   Altunhan, Huseyin ^c   Erbay, Ekrem ^a   Örs, Rahmi ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

^c ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Ischemia modified albumin; Late onset neonatal sepsis; Procalcitonin; White blood cell count

Indexed keywords

C REACTIVE PROTEIN; ISCHEMIA MODIFIED ALBUMIN; PROCALCITONIN; BIOLOGICAL MARKER; ISCHEMIA-MODIFIED ALBUMIN; SERUM ALBUMIN;

ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LATE ONSET NEWBORN SEPSIS; LEUKOCYTE COUNT; MALE; NEWBORN; NEWBORN SEPSIS; PREMATURITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; GESTATIONAL AGE; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE, DISEASES; ONSET AGE; SEPSIS;

AGE OF ONSET; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LEUKOCYTE COUNT; MALE; SEPSIS; SERUM ALBUMIN;

EID: 84911924315     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.876621     Document Type: Article

References (32)

1. Campos DP, Silva MV, Machado JR, et al. Early-onset neonatal sepsis: cord blood cytokine levels at diagnosis and during treatment. J Pediatr (Rio J) 2010;86:509-14.
2. Valerio TA, Cancelier CA, Constantino L, et al. Inflammatory and oxidative cord blood parameters as predictors of neonatal sepsis severity. Rev Bras Ter Intensiva 2012;24:30-4.
3. Altunhan H, Annagür A, Örs R, Mehmetoʇlu I. Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int J Infect Dis 2011;15:854-8.
4. Zhang Y, Xue C, Zhu T, et al. Serum bone alkaline phosphatase in assessing illness severity of infected neonates in the neonatal intensive care unit. Int J Biol Sci 2012;8:30-8.
5. Kite P, Millar MR, Gorham P, Congdon P. Comparison of five tests used in diagnosis of neonatal bacteraemia. Arch Dis Child 1988;63:639-43.
6. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979;95:89-98.
7. Kurt AN, Aygun AD, Godekmerdan A, et al. Serum IL-1beta, IL-6, IL-8, and TNF-alpha levels in early diagnosis and management of neonatal sepsis. Mediators Inflamm 2007;2007:31397. doi: 10.1155/2007/31397.
8. Gerdes JS. Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol 1991;18:361-81.
9. Caldas JP, Marba ST, Blotta MH, et al. Accuracy of white blood cell count, C-reactive protein, interleukin-6 and tumor necrosis factor alpha for diagnosing late neonatal sepsis. J Pediatr (Rio J) 2008;84:536-42.
10. Dursun A, Okumus N, Zenciroglu A. Ischemia-modified albumin (IMA): could it be useful to predict perinatal asphyxia? J Matern Fetal Neonatal Med 2012;25:2401-5.
11. Gugliucci A, Hermo R, Monroy C, et al. Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005;362:155-60.
12. Chan B, Dodsworth N, Woodrow J, et al. Site-specific N-terminal auto-degradation of human serum albumin. Eur J Biochem 1995;227:524-8.
13. Zuwała-Jagiełło J, Warwas M, Pazgan-Simon M. Ischemia-modified albumin (IMA) is increased in patients with chronic hepatitis C infection and related to markers of oxidative stress and inflammation. Acta Biochim Pol 2012;59:661-7.
14. Kaefer M, Piva SJ, De Carvalho JA, et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem 2010;43:450-4.
15. Mehmetoglu I, Yerlikaya FH, Kurban S, et al. Oxidative stress markers in hemodialysis and peritoneal dialysis patients, including coenzyme Q10 and ischemia-modified albumin. Int J Artif Organs 2012;35:226-32.
16. Kotani K, Caccavello R, Sakane N, et al. Influence of ezetimibe monotherapy on ischemia-modified albumin levels in hypercholesterolemic patients. Pharmacol Rep 2011;63:1248-51.
17. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as marker its potential as a marker for myocardial ischemia-A preliminary report. J Emer Med 2000;19:311-15.
18. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Standardization of ischaemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 2007;45:261-2.
19. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J 2009;28:3-9.
20. Erdem SS, Yerlikaya FH, Çic¸ekler H, Gül M. Association between ischemia-modified albumin, homocysteine, vitamin B 12 and folic acid in patients with severe sepsis. Clin Chem Lab Med 2012;50:1417-21.
21. Gutteridge JM, Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 2000;899:136-47.
22. Chan B, Dodsworth N, Woodrow J, et al. Sitespecific N-terminal auto-degradation of human serum albumin. Eur J Biochem 1995;227:524-8.
23. Taylor DE, Piantadosi CA. Oxidative metabolism in sepsis and sepsis syndrome. J Crit Care 1995;10:122-35.
24. Cherian S, Jameson S, Rajarajeswari C, et al. Oxidative stress in sepsis in children. Indian J Med Res 2007;125:143-8.
25. Batra S, Kumar R, Kapoor AK, Ray G. Alterations in antioxidant status during neonatal sepsis. Ann Trop Paediatr 2000;20:27-33.
26. Kaefer M, Piva SJ, De Carvalho JA, et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem 2010;43:450-4.
27. Duarte MM, Rocha JB, Moresco RN, et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009;42:666-71.
28. Buhaescu I, Yood RA, Izzedine M. Serum procalcitonin in systemic autoimmune diseases - where are we now? Semin Arthritis Rheum 2010;40:176-83.
29. Ertuʇrul S, Annagur A, Kurban S, et al. Comparison of urinary neutrophil gelatinase-associated lipocalin, C-reactive protein and procalcitonin in the diagnosis of late onset sepsis in preterm newborns. J Matern Fetal Neonatal Med 2013;26:430-3.
30. Greenberg DN, Yoder BA. Changes in the differential white blood cell count in screening for group B streptococcal sepsis. Pediatr Infect Dis J 1990;9:886-9.
31. Ottolini MC, Lundgren K, Mirkinson LJ, et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003;22:430-4.
32. Christensen RD, Rothstein G, Hill HR, Hall RT. Fatal early onset group B streptococcal sepsis with normal leukocyte counts. Pediatr Infect Dis 1985;4:242-5.